Categories: Business

NYSE Content Advisory: Pre-Market update + Trump sets 35% tariff on Canada

NEW YORK, July 11, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on July 11th

- Advertisement -
  • After the S&P 500 finished at a record on Thursday, equities are lower this morning following President Donald Trump’s announcement of a 35% levy on Canada beginning on August 1st.
  • President Trump said Fentanyl was the reason for the tariffs. Canadian Prime Minister Mark Carney replied on X saying, “we are committed to continuing to work with the U.S to save lives and protect communities.”
  • During the first full week of July Trade, President Trump extended the July 9th tariff deadline to August 1st. He’s added new levies as well, including some on more than a dozen countries like Japan and South Korea.

Opening Bell
FIFA and DAZN celebrate the FIFA Club World Cup 2025 Final between Chelsea FC and Paris Saint-Germain

- Advertisement -

Closing Bell
Jim Cramer and the CNBC Investing Club team celebrate the club’s 3rd annual meeting

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2729457/NYSE_Market_Update_July_11.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–trump-sets-35-tariff-on-canada-302503292.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago